Sucampo Pharmaceuticals, Inc.·4

Oct 5, 4:35 PM ET

Driggs Alex 4

4 · Sucampo Pharmaceuticals, Inc. · Filed Oct 5, 2017

Insider Transaction Report

Form 4
Period: 2017-09-30
Driggs Alex
General Counsel & Corp. Sec.
Transactions
  • Award

    Common Stock, Class A (ESPP)

    2017-09-30$9.10/sh+659$5,9971,331 total
Footnotes (2)
  • [F1]The reporting person is voluntarily reporting the acquisition of common stock pursuant to the issuer's Employee Stock Purchase Plan (ESPP) for the period July 1, 2017 through September 30, 2017. This transaction is exempt under Rule 16(b)-3(c).
  • [F2]In accordance with the ESPP, these shares were purchased at 85% of the July 3, 2017 closing price of the issuer's common stock.

Documents

1 file
  • 4
    formfour.xmlPrimary

    OWNERSHIP DOCUMENT